INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Institute
University of Lyon System
Lyon, FranciaPublications in collaboration with researchers from University of Lyon System (10)
2021
-
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial
The Lancet Oncology, Vol. 22, Núm. 4, pp. 463-475
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2018
-
Rituximab plus lenalidomide in advanced untreated follicular lymphoma
New England Journal of Medicine, Vol. 379, Núm. 10, pp. 934-946
2017
2016
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222
-
The first meeting of the European Register of Cystic Echinococcosis (ERCE)
Parasites and Vectors, Vol. 9, Núm. 1
2013
-
In situ preparation of a multifunctional chiral hybrid organic-inorganic catalyst for asymmetric multicomponent reactions
Chemical Science, Vol. 4, Núm. 5, pp. 2006-2012
2012
-
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy, Vol. 8, Núm. 4, pp. 445-544